Authors

Dr Herzberg on Management Challenges in STK11/KEAP1+, SMARCA4-Deficient Undifferentiated Tumors and NUT Carcinoma

Benjamin Herzberg, MD, discusses the management challenges associated with STK11/KEAP1-mutated tumors, SMARCA4-deficient undifferentiated tumors, and NUT carcinoma.

Clinical Trial to Evaluate Blood Test for Early Detection of Breast Cancer

A new clinical trial will investigate whether a simple blood test could help detect breast cancer as early as Stage I.

CAR T Pioneers Describe Challenges Faced in Cancer

Advances of chimeric antigen receptor T-cell therapy technologies are in rapid development and under investigation in a range of preclinical and clinical research around the globe.

UAMS Winthrop P. Rockefeller Cancer Institute Pushes Liquid Biopsy Research Forward

The use of a routine blood test to assess and monitor patients with cancer, especially in a longitudinal manner, has long been the holy grail of cancer research.

Unprecedented Advances Fuel Progress in the Treatment of AL Amyloidosis

Light-chain amyloidosis is a rare plasma cell disorder that involves the production of a misfolded amyloidogenic light chain by a plasma cell clone that deposits in various organs leading to organ failure.

Media Training Helps Investigators, Institutions Shine

Here are 5 tips and tricks to help you shine when the spotlight is on you.

OncLive® and the Ruesch Center for the Cure of Gastrointestinal Cancers announce recipients of the 2025 Luminary Awards in GI Cancer

OncLive® and the Ruesch Center at Georgetown Lombardi announce the 2025 Luminary Award winners in gastrointestinal cancers.

Improving Outcomes for AML Patients with Genetic Testing and Targeted Therapy

43rd Annual Chemotherapy Foundation Symposium: The Show and After Show

Welcome to The Show and After-Show with Andrew Svonavec and Kristie L. Kahl, your essential guide to the 43rd Annual Chemotherapy Foundation Symposium (CFS).

Expert Teams, Exceptional Outcomes: AHN Cancer Institute’s Disease Site Centers Drive Innovation

AHN Cancer Institute’s Centers of Excellence unite teams of experts to provide patients with high-quality, collaborative care in a supportive environment.

Choosing Your Path

Megan M. Dupuis, MD, shares the complex journey she traveled during medical training and how it brought her to the academic setting.

Targeting Transcription as a New Frontier in Advanced Pancreatic Cancer

A new focus of research has reconsidered the mechanisms in regulating transcription as a novel target for advanced pancreatic ductal adenocarcinoma.

The Public Library of the Future Could Stand as a Critical Force for Evidence-Based Health and Cancer Information

Public libraries will play a role in developing essential reading skills, improving financial literacy, and fostering critical thinking.

Oncology Fellows Derive the Greatest Benefit From Advanced Research Training

Aimed at growing the translational workforce, most hubs offer different accelerated advanced degree opportunities to oncology trainees, such as master’s degrees in clinical and/or translational research, or graduate certificates.

Enfortumab Vedotin Shows Manageable Safety in Older Patients With Urothelial Carcinoma

Enfortumab vedotin demonstrated a manageable safety profile and no unexpected toxicities in patients aged 80 years and older with urothelial carcinoma.

Getting the Best From Mentorship

Mentors may help in career development, personal matters, research activities, and professional growth.

Frontline Therapeutic Planning for Metastatic Renal Cell Carcinoma

In this review, authors highlight multidisciplinary treatment for patients with advanced disease, and integrating systemic therapy options with surgery and radiation therapy.

In the Trenches With the Fellows

Mili Arora, MD, talks about changing the fellowship program at UC Davis, the effect the COVID-19 pandemic has had on her trainees, and the importance of working late nights with her fellows.

Zanubrutinib May Be Viable Option After Acalabrutinib Intolerance in B-Cell Malignancies

Patients with B-cell malignancies who were intolerant to treatment with acalabrutinib experienced clinically meaningful benefits when treated with zanubrutinib, suggesting zanubrutinib may be a viable treatment option for this population.

Stage Is Set for Continued Progress in the Melanoma Clinic

Unprecedented treatment advances have been made during the last decade for patients with advanced melanoma.

ASCP’s Outstanding Education Initiatives Receive Prestigious Awards

Two innovative ASCP education initiatives have received accolades from the Alliance for Continuing Education in the Health Professions.

Managing Unseen Risks: Understanding Recurrence in Early Breast Cancer With No or Limited Nodal Involvement

A Conversation about Somatic, Incidental Germline, and Standalone Germline Testing in Clinical Practice

Sponsored Content by Tempus

The Role of Genetics in Cancer Care Continues to Expand

Genetic screening and testing have only recently become an integral part of cancer care.

World Lung Cancer Expert Diagnosed with Advanced Lung Cancer

D. Ross Camidge, MD, PhD, has spent his career fighting lung cancer. In 2022, that fight turned personal when he received a diagnosis of his own.

The Power of No, the Value of Yes

Brian I. Rini, MD, and Matthew Tucker, MD, sit down to discuss developing a career path and building a résumé, the value of writing review articles early in fellowship, the power of saying no, and the importance of saying yes.

Fellows Can Join the Fight Against Cancer Misinformation Online

Many cancer organizations across the United States and internationally acknowledge a need for in-novative uses of social technology to improve cancer-related support and information provision.

Gemcitabine Intravesical System Yields Low Rate of Radical Cystectomy in BCG-Unresponsive, High-Risk NMIBC

Gemcitabine intravesical system in BCG-unresponsive, high-risk NMIBC led to high CR rates and low radical cystectomy rates.